SEC Comment Letter for INSMED Inc (INSM) (CIK 0001104506) (INSM) — Jan 5, 2021
INSMED Inc (INSM) (CIK 0001104506)
Date: Jan. 5, 2021 · CIK: 0001104506 · Accession: 0000000000-21-000059
AI Filing Summary & Sentiment
File numbers found in text: 000-30739
Letter
United States securities and exchange commission logo January 5, 2021 Sara Bonstein Chief Financial Officer INSMED Inc 700 US Highway 202/206 Bridgewater, NJ 08807 Re:INSMED Inc Form 10-K filed February 25, 2020 File No. 000-30739 Dear Ms. Bonstein: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
January 5, 2021
Sara Bonstein
Chief Financial Officer
INSMED Inc
700 US Highway 202/206
Bridgewater, NJ 08807
Re:INSMED Inc
Form 10-K filed February 25, 2020
File No. 000-30739
Dear Ms. Bonstein:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences